Article Versions Notes

Derrick C, Bookstaver PB, Lu ZK, Bland CM, King ST, Stover KR, Rumley K, MacVane SH, Swindler J, Kincaid S, et al. Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to Enterobacter, Serratia, and Citrobacter Species. Antibiotics. 2020; 9(5):254. https://doi.org/10.3390/antibiotics9050254

Derrick, Caroline, P. Brandon Bookstaver, Zhiqiang K. Lu, Christopher M. Bland, S. Travis King, Kayla R. Stover, Kathey Rumley, Shawn H. MacVane, Jenna Swindler, Scott Kincaid, and et al. 2020. "Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to Enterobacter, Serratia, and Citrobacter Species" Antibiotics 9, no. 5: 254. https://doi.org/10.3390/antibiotics9050254

Derrick, C., Bookstaver, P. B., Lu, Z. K., Bland, C. M., King, S. T., Stover, K. R., Rumley, K., MacVane, S. H., Swindler, J., Kincaid, S., Branan, T., Cluck, D., Britt, B., Pillinger, K. E., Jones, B. M., Fleming, V., DiMondi, V. P., Estrada, S., Crane, B., ... Justo, J. A., on behalf of the SERGE-45 Investigators. (2020). Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to Enterobacter, Serratia, and Citrobacter Species. Antibiotics, 9(5), 254. https://doi.org/10.3390/antibiotics9050254